Morten Ruhwald | Chief Medical Officer
Novo Nordisk Foundation Initiative for Vaccines and Immunity

Morten Ruhwald is a seasoned healthcare executive with a strong background in medical affairs and strategic leadership. Currently serving as the Chief Medical Officer at Novo Nordisk Foundation Initiative for Vaccines and Immunity (NIVI-D), Morten is a  medical Doctor with extensive scientific credentials and a comprehensive understanding of the lifecycle of health commodities in infectious diseases. Demonstrated expertise in translational research and product development, successfully bringing innovative vaccines, biologics and diagnostics to market. He possesses a robust scientific foundation and medical proficiency, having led, and contributed to clinical trial design, data analysis, and evaluation of study outcomes for both regulatory approval and policy formulation. Proven experience in collaborating with key opinion leaders, national health programs, and policy makers to advance novel products and ensure their integration into health systems globally. Exhibits strong leadership skills, effectively managing cross-functional, matrixed teams and overseeing complex projects across diverse regions and cultures, meeting tight timelines and budgets.

As a thought leader in the vaccine industry, Morten is passionate about leveraging his medical expertise to address pressing global health challenges. He is known for his collaborative approach to problem-solving and his ability to build strong relationships with key stakeholders across the healthcare ecosystem.

At the World Vaccine Congress Europe 2025, Morten will share his insights on the latest trends in vaccine research, development, and strategic partnering. His presentation promises to offer valuable perspectives on the future of the global vaccine industry and the critical role that innovation and collaboration play in driving positive health outcomes worldwide.

With Morten Ruhwald at the helm, NIVI-D is well-positioned to continue its legacy of excellence in vaccine development and make a meaningful impact on public health on a global scale.